KDM4C and acute myeloid leukemia: Consistently, at the molecular level, KDM4A KD led to transcriptional changes distinct from KDM4C KD via GSEA comparison (Fig. S6C), further supporting a unique role for KDM4A compared to KDM4C in human AML.